{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:02:19Z","timestamp":1790416939618,"version":"4.1.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jaut.2015.10.006","type":"journal-article","created":{"date-parts":[[2015,11,22]],"date-time":"2015-11-22T00:37:53Z","timestamp":1448152673000},"page":"98-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["The clinical phenotypes of autoimmune hepatitis: A comprehensive review"],"prefix":"10.1016","volume":"66","author":[{"given":"Qixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Krawitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2015.10.006_bib1","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.3748\/wjg.14.3292","article-title":"Historical reflections on autoimmune hepatitis","volume":"14","author":"Mackay","year":"2008","journal-title":"World J. Gastroenterol. WJG"},{"key":"10.1016\/j.jaut.2015.10.006_bib2","first-page":"119","article-title":"Effect of prednisone on the survival of patients with cirrhosis of the liver. A report from the Copenhagen Study group for liver diseases","volume":"1","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2015.10.006_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis","volume":"40","author":"Cook","year":"1971","journal-title":"Q.\u00a0J. Med."},{"key":"10.1016\/j.jaut.2015.10.006_bib4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2015.10.006_bib5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","author":"Murray-Lyon","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2015.10.006_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/gut.21.1.78","article-title":"Late results of the royal free hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis","volume":"21","author":"Kirk","year":"1980","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2015.10.006_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib8","first-page":"210","article-title":"Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the international autoimmune hepatitis group","volume":"42","author":"Miyake","year":"2010","journal-title":"Dig. Liver Dis. Off. J. Italian Soc. Gastroenterol. Italian Assoc. Study Liver"},{"key":"10.1016\/j.jaut.2015.10.006_bib9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2010.06.032","article-title":"Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients","volume":"54","author":"Qiu","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib10","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3109\/00365521.2014.946083","article-title":"Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands","volume":"49","author":"van Gerven","year":"2014","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib11","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Population-based epidemiology study of autoimmune hepatitis: a disease of older women?","volume":"25","author":"Ngu","year":"2010","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib12","first-page":"602","article-title":"Profiles of autoimmune hepatitis in Brunei Darussalam","volume":"8","author":"Jalihal","year":"2009","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.jaut.2015.10.006_bib13","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1046\/j.1440-1746.2001.02646.x","article-title":"Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women","volume":"16","author":"Lee","year":"2001","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/1751-2980.12085","article-title":"Autoimmune hepatitis in southern Israel: a 15-year multicenter study","volume":"14","author":"Delgado","year":"2013","journal-title":"J.\u00a0Dig. Dis."},{"key":"10.1016\/j.jaut.2015.10.006_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1445-5994.2009.02041.x","article-title":"Autoimmune hepatitis in a demographically isolated area of Australia","volume":"40","author":"Haider","year":"2010","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.jaut.2015.10.006_bib16","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study","volume":"43","author":"Werner","year":"2008","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0210-5705(03)70452-X","article-title":"Incidence and prevalence of autoimmune hepatitis in the area of the hospital de Sagunto (Spain)","volume":"27","author":"Primo","year":"2004","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gronbaek","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib20","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jaut.2015.10.006_bib21","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib22","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib23","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British society of G. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","author":"Gleeson","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2015.10.006_bib24","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis\u2013update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"American association for the study of liver D. diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpgasthep0768","article-title":"Current therapy for autoimmune hepatitis","volume":"4","author":"Montano Loza","year":"2007","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","article-title":"Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis","volume":"139","author":"Czaja","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2015.10.006_bib28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bpg.2011.09.011","article-title":"Autoimmune hepatitis in special patient populations","volume":"25","author":"Czaja","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2015.10.006_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaut.2015.08.016","article-title":"Using GWAS to identify genetic predisposition in hepatic autoimmunity","volume":"66","author":"Webb","year":"2016","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.10.006_bib31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","article-title":"Genetic basis of myasthenia gravis \u2013 a comprehensive review","volume":"52","author":"Avidan","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.10.006_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2013.10.001","article-title":"DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology","volume":"50","author":"Stefan","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.10.006_bib33","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"Electronic address eee. EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","author":"European Association for the Study of the Liver","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14740338.7.3.319","article-title":"Safety issues in the management of autoimmune hepatitis","volume":"7","author":"Czaja","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jaut.2015.10.006_bib35","first-page":"351","article-title":"Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis","volume":"23","author":"Ben Ari","year":"1995","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4103\/0253-7613.89840","article-title":"Azathioprine induced cholestatic hepatitis","volume":"43","author":"Moses","year":"2011","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.jaut.2015.10.006_bib37","first-page":"914","article-title":"Severe cholestatic acute hepatitis following azathioprine therapy in a patient with ulcerative pancolitis","volume":"41","author":"Roda","year":"2009","journal-title":"Dig. Liver Dis. Off. J. Italian Soc. Gastroenterol. Italian Assoc. Study Liver"},{"key":"10.1016\/j.jaut.2015.10.006_bib38","first-page":"249","article-title":"Cholestatic hepatitis due to azathioprine and tacrolimus in a adult renal allograft recipient","volume":"27","author":"Sidhu","year":"2008","journal-title":"Indian J. Gastroenterol. Off. J. Indian Soc. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.autrev.2011.09.006","article-title":"Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome","volume":"11","author":"Efe","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2015.10.006_bib40","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2015.10.006_bib41","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jpeds.2013.05.042","article-title":"Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents","volume":"163","author":"Woynarowski","year":"2013","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.jaut.2015.10.006_bib42","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jpeds.2013.06.064","article-title":"Budesonide for juvenile autoimmune hepatitis? Not yet","volume":"163","author":"Mieli-Vergani","year":"2013","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.jaut.2015.10.006_bib43","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1155\/2010\/891252","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy","volume":"24","author":"Sharzehi","year":"2010","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib44","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib45","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","author":"Hennes","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2036.2011.04727.x","article-title":"The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes","volume":"34","author":"Baven-Pronk","year":"2011","journal-title":"Alimentary Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2015.10.006_bib47","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ajmg.a.33934","article-title":"An additional patient with mycophenolate mofetil embryopathy: cardiac and facial analyses","volume":"155A","author":"Lin","year":"2011","journal-title":"Am. J. Med. Genet. Part A"},{"issue":"32","key":"10.1016\/j.jaut.2015.10.006_bib48","doi-asserted-by":"crossref","first-page":"33849","DOI":"10.18632\/oncotarget.5292","article-title":"Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage","volume":"6","author":"Crane","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaut.2015.10.006_bib49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2036.2011.04749.x","article-title":"Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience","volume":"34","author":"Tannous","year":"2011","journal-title":"Alimentary Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2015.10.006_bib50","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1651-2227.2012.02745.x","article-title":"Tacrolimus without or with the addition of conventional immunosuppressive treatment in juvenile autoimmune hepatitis","volume":"101","author":"Marlaka","year":"2012","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.jaut.2015.10.006_bib51","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib52","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1010683817344","article-title":"Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis","volume":"46","author":"Malekzadeh","year":"2001","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2015.10.006_bib53","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1080\/00365520310005082","article-title":"Pharmacological monitoring of azathioprine therapy","volume":"38","author":"Reuther","year":"2003","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib54","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/0016-5085(89)91701-0","article-title":"Prognosis of corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis in postmenopausal women: a retrospective analysis","volume":"97","author":"Wang","year":"1989","journal-title":"Gastroenterology"},{"issue":"89","key":"10.1016\/j.jaut.2015.10.006_bib55","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/0016-5085(85)90212-4","article-title":"Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy","volume":"1985","author":"Stellon","year":"1985","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2015.10.006_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00535-010-0324-3","article-title":"Discrimination of autoimmune hepatitis: autoantibody typing and beyond","volume":"46","author":"Krawitt","year":"2011","journal-title":"J.\u00a0Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib57","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/hep.23840","article-title":"Treatment response in patients with autoimmune hepatitis","volume":"52","author":"Schramm","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib58","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","article-title":"Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre","volume":"45","author":"Al-Chalabi","year":"2006","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib59","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/0016-5085(93)91081-R","article-title":"Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2015.10.006_bib60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12016-014-8432-0","article-title":"Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis","volume":"48","author":"Miao","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2015.10.006_bib61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/jhep.2001.27562","article-title":"Autoimmune hepatitis with incidental histologic features of bile duct injury","volume":"34","author":"Czaja","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib62","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib63","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib64","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib65","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/hep.22825","article-title":"Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients","volume":"49","author":"Muratori","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib66","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejim.2010.02.009","article-title":"Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for post-transplant Lymphoproliferative Disease (PTLD)","volume":"21","author":"Zimmermann","year":"2010","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jaut.2015.10.006_bib67","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib68","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1007\/s10620-011-1769-9","article-title":"Cryptogenic chronic hepatitis and its changing guise in adults","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2015.10.006_bib69","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jcp.29.5.403","article-title":"Classification of smooth muscle autoantibodies detected by immunofluorescence","volume":"29","author":"Bottazzo","year":"1976","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.jaut.2015.10.006_bib70","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1023\/A:1018809431189","article-title":"Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis","volume":"42","author":"Czaja","year":"1997","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2015.10.006_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.08.004","article-title":"Autoimmune hepatitis: contrasts and comparisons in children and adults \u2013 a comprehensive review","volume":"46","author":"Floreani","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.10.006_bib72","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group","volume":"41","author":"Vergani","year":"2004","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib73","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.26666","article-title":"Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis","volume":"59","author":"Couto","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib74","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s10620-006-9665-4","article-title":"Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis","volume":"52","author":"Gassert","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2015.10.006_bib75","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2015.10.006_bib76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/1751-2980.12022","article-title":"Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients: a single center experience","volume":"14","author":"Wang","year":"2013","journal-title":"J.\u00a0Dig. Dis."},{"key":"10.1016\/j.jaut.2015.10.006_bib77","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib78","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3350\/cmh.2013.19.3.305","article-title":"Co-development of autoimmune hepatitis and Sjogren's syndrome triggered by the administration of herbal medicines","volume":"19","author":"Oh","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib79","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/1752-1947-4-311","article-title":"Autoimmune hepatitis triggered by nitrofurantoin: a case series","volume":"4","author":"Appleyard","year":"2010","journal-title":"J.\u00a0Med. case Rep."},{"key":"10.1016\/j.jaut.2015.10.006_bib80","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/hep.23834","article-title":"Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor alpha agents","volume":"52","author":"Efe","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib81","article-title":"Natural history and outcomes in drug-induced autoimmune hepatitis","author":"Yeong","year":"2015","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jaut.2015.10.006_bib82","first-page":"583","article-title":"Herb-induced autoimmune-like hepatitis in C57BL\/6J mice","volume":"34","author":"Wang","year":"2014","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.jaut.2015.10.006_bib83","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2015.10.006_bib84","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/17474124.1.1.113","article-title":"Autoimmune hepatitis. Part A: pathogenesis","volume":"1","author":"Czaja","year":"2007","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib85","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0034-1375959","article-title":"Drug-induced liver injury with autoimmune features","volume":"34","author":"deLemos","year":"2014","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jaut.2015.10.006_bib86","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJM199006283222601","article-title":"Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients","volume":"322","author":"Ahonen","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2015.10.006_bib87","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2010.08.019","article-title":"Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity","volume":"10","author":"Fierabracci","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2015.10.006_bib88","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.immuni.2015.04.021","article-title":"Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases","volume":"42","author":"Oftedal","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.10.006_bib89","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jaapos.2006.06.018","article-title":"Ocular complications of autoimmune polyendocrinopathy syndrome type 1","volume":"10","author":"Chang","year":"2006","journal-title":"J.\u00a0AAPOS Off. Publ. Am. Assoc. Pediatr. Ophthalmol. Strabismus Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"key":"10.1016\/j.jaut.2015.10.006_bib90","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib91","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib92","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/jgh.12952","article-title":"Autoimmune hepatitis: east meets west","volume":"30","author":"Yang","year":"2015","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib93","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaut.2012.10.004","article-title":"Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis","volume":"41","author":"Wang","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.10.006_bib94","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib95","first-page":"863","article-title":"Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis","volume":"12","author":"Ozaslan","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.jaut.2015.10.006_bib96","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib97","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.1840360615","article-title":"Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome","volume":"36","author":"Abdo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib98","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0168-8278(96)80266-2","article-title":"Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis","volume":"24","author":"Gohlke","year":"1996","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","article-title":"Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"43","author":"Luth","year":"2009","journal-title":"J.\u00a0Clin. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib100","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","author":"Carbone","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib101","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5582\/irdr.2014.01034","article-title":"Liver transplantation and autoimmune hepatitis","volume":"4","author":"Tanaka","year":"2015","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.jaut.2015.10.006_bib102","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0012.2004.00117.x","article-title":"Long-term outcome of liver transplantation for autoimmune hepatitis","volume":"18","author":"Vogel","year":"2004","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.jaut.2015.10.006_bib103","first-page":"1281","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"key":"10.1016\/j.jaut.2015.10.006_bib104","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long-term pathologic study","volume":"32","author":"Ayata","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib105","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib106","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/jhep.2002.35339","article-title":"Autoimmunity after liver transplantation","volume":"36","author":"Vergani","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib107","first-page":"302","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","author":"Gonzalez-Koch","year":"2001","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"key":"10.1016\/j.jaut.2015.10.006_bib108","first-page":"1426","article-title":"Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation","volume":"32","author":"Montano-Loza","year":"2012","journal-title":"Liver Internat. Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.jaut.2015.10.006_bib109","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0031-1272834","article-title":"De novo autoimmune hepatitis after liver transplantation","volume":"31","author":"Guido","year":"2011","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jaut.2015.10.006_bib110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jhep.2003.10.022","article-title":"De novo autoimmune hepatitis after liver transplantation","volume":"40","author":"Mieli-Vergani","year":"2004","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib111","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients","volume":"35","author":"Kogan","year":"2002","journal-title":"J.\u00a0Clin. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib112","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib113","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1872-034X.2012.01109.x","article-title":"Prognosis of autoimmune hepatitis showing acute presentation","volume":"43","author":"Yamamoto","year":"2013","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib114","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2014.06.030","article-title":"Acute autoimmune hepatitis: many open questions","volume":"61","author":"Weiler-Normann","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib115","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/hep.23042","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease","volume":"50","author":"Yeoman","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib116","first-page":"625","article-title":"Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis","volume":"2","author":"Kessler","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.jaut.2015.10.006_bib117","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1111\/j.1572-0241.2002.06052.x","article-title":"Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature","volume":"97","author":"Singh","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib118","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1386-6346(02)00274-7","article-title":"Clinicopathological features of acute-onset autoimmune hepatitis","volume":"25","author":"Okano","year":"2003","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib119","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jcp.2005.029348","article-title":"Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation","volume":"59","author":"Hofer","year":"2006","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.jaut.2015.10.006_bib120","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib121","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00000478-200404000-00006","article-title":"Autoimmune hepatitis with centrilobular necrosis","volume":"28","author":"Misdraji","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jaut.2015.10.006_bib122","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0029-1233529","article-title":"Autoimmune hepatitis in children: what is different from adult AIH?","volume":"29","author":"Mieli-Vergani","year":"2009","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jaut.2015.10.006_bib123","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0168-8278(94)80251-3","article-title":"The nature and prognostic implications of autoimmune hepatitis with an acute presentation","volume":"21","author":"Nikias","year":"1994","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib124","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jhep.2014.05.021","article-title":"Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome","volume":"61","author":"Yeoman","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib125","first-page":"996","article-title":"Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis","volume":"13","author":"Ichai","year":"2007","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"key":"10.1016\/j.jaut.2015.10.006_bib126","first-page":"953","article-title":"Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation","volume":"13","author":"Czaja","year":"2007","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"key":"10.1016\/j.jaut.2015.10.006_bib127","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2007.08.013","article-title":"Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis","volume":"48","author":"Al-Chalabi","year":"2008","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib128","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.24141","article-title":"Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis","volume":"53","author":"Yeoman","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2015.10.006_bib129","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3748\/wjg.v13.i23.3232","article-title":"Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis","volume":"13","author":"Larsen","year":"2007","journal-title":"World J. Gastroenterol. WJG"},{"issue":"16","key":"10.1016\/j.jaut.2015.10.006_bib130","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","article-title":"Prednisone for chronic active liver disease:dose titration,standard dose and combination with azathioprine compound","volume":"1975","author":"Summerskill","year":"1975","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2015.10.006_bib131","first-page":"331","article-title":"Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects","volume":"6","author":"Uribe","year":"1984","journal-title":"J.\u00a0Clin. Gastroenterol."},{"key":"10.1016\/j.jaut.2015.10.006_bib132","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s10620-006-9336-5","article-title":"Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis","volume":"51","author":"Czaja","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2015.10.006_bib133","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2006.05.011","article-title":"Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis","volume":"45","author":"Heneghan","year":"2006","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jaut.2015.10.006_bib134","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/apt.12470","article-title":"Review article: autoimmune hepatitis \u2013 current management and challenges","volume":"38","author":"Zachou","year":"2013","journal-title":"Alimentary Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2015.10.006_bib135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaut.2014.07.005","article-title":"Epitope-based approaches to a universal influenza vaccine","volume":"54","author":"Gottlieb","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.10.006_bib136","first-page":"255","article-title":"Mechanisms of autoimmune liver disease","volume":"18","author":"Baier","year":"2014","journal-title":"Discov. Med."},{"key":"10.1016\/j.jaut.2015.10.006_bib137","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12016-014-8446-7","article-title":"Extrahepatic malignancies in primary biliary cirrhosis: a comparative study at two European centers","volume":"48","author":"Floreani","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2015.10.006_bib138","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.10.006_bib139","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12016-014-8419-x","article-title":"Genetics in PBC: what do the \u201crisk genes\u201d teach us?","volume":"48","author":"Hirschfield","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2015.10.006_bib140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2014.02.001","article-title":"Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2","volume":"53","author":"Holder","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.10.006_bib141","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaut.2014.01.034","article-title":"Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells","volume":"50","author":"Huang","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.10.006_bib142","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12016-014-8442-y","article-title":"Animal models in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"48","author":"Pollheimer","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2015.10.006_bib143","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11684-015-0386-y","article-title":"Autoimmune hepatitis","volume":"9","author":"Sahebjam","year":"2015","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2015.10.006_bib144","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2015.01.011","article-title":"Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis","volume":"59","author":"Wang","year":"2015","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.10.006_bib145","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaut.2014.10.006","article-title":"Retention and tolerance of autoreactive CD4(+) recent thymic emigrants in the liver","volume":"56","author":"Xu","year":"2015","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.10.006_bib146","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2014.02.009","article-title":"Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Ralpha(-\/-) mice","volume":"51","author":"Yao","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.10.006_bib147","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12016-014-8418-y","article-title":"Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review","volume":"48","author":"Yip","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2015.10.006_bib148","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2014.02.010","article-title":"The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury","volume":"53","author":"Zhang","year":"2014","journal-title":"J.\u00a0Autoimmun."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841115300512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841115300512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:12:36Z","timestamp":1760256756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841115300512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":148,"alternative-id":["S0896841115300512"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2015.10.006","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical phenotypes of autoimmune hepatitis: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}